ESBLs (extended-spectrum beta-lactamases) are bacterial enzymes that can break down certain beta-lactam antibiotics, thereby rendering them ineffective.
In fecal microbiota transplantation (FMT), processed fecal microbiota from the stool of healthy donors is transferred to patients to modulate their gut microbiome.